Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort.
care delays
general practitioner
localized potential accessibility
pancreatic adenocarcinoma
pancreatic surgery
socio-spatial disparities
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
03 Nov 2022
03 Nov 2022
Historique:
received:
03
10
2022
revised:
29
10
2022
accepted:
31
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Background and aims: Pancreatic cancer is highly lethal and often diagnosed at an advanced stage. This cohort study analyzes the impact of care pathways, delays, and socio-spatial determinants on pancreatic cancer patients’ diagnosis, treatment, and prognosis. Method: Patients with pancreatic adenocarcinoma newly diagnosed at all stages between January and June 2016 in the AuRA French region were included. The influence on survival of delays of care, healthcare centers’ expertise, and socio-spatial determinants was evaluated. Results: Here, 538 patients were included in 76 centers including 116 patients (21.8%) with resectable, 64 (12.0%) borderline-resectable, 147 (27.6%) locally-advanced tumors, and 205 (38.5%) with metastatic disease. A delay between first symptoms and CT scans did not statistically influence overall survival (OS). In resected patients, OS was significantly higher in centers with more than 20 surgeries (HR<5 surgeries/year = 2.236 and HR5-20 surgeries/year = 1.215 versus centers with > 20 surgeries/year p = 0.0081). Regarding socio-spatial determinants, patients living in municipalities with greater access to a general practitioner (HR = 1.673, p = 0.0153) or with a population density below 795.1 people/km2 (HR = 1.881, p = 0.0057) were significantly more often resectable. Conclusion: This cohort study supports the pivotal role of general practitioner in cancer care and the importance of the centralization of pancreatic surgery to optimize pancreatic cancer patients’ care and outcomes. However, delays of care did not impact patient survival.
Identifiants
pubmed: 36358831
pii: cancers14215413
doi: 10.3390/cancers14215413
pmc: PMC9658615
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
BMC Surg. 2021 Dec 7;21(1):413
pubmed: 34876080
Br J Cancer. 2015 Mar 31;112 Suppl 1:S41-9
pubmed: 25734388
Scand J Surg. 2020 Mar;109(1):4-10
pubmed: 31969066
Br J Cancer. 2022 Jun;126(10):1490-1498
pubmed: 35149855
Cancers (Basel). 2021 Jul 14;13(14):
pubmed: 34298729
Future Oncol. 2020 Jul;16(19):1385-1392
pubmed: 32412798
PLoS One. 2016 Nov 10;11(11):e0166449
pubmed: 27832174
Surg Oncol Clin N Am. 2021 Oct;30(4):759-771
pubmed: 34511195
Int J Health Geogr. 2020 Nov 9;19(1):46
pubmed: 33298076
Nat Rev Clin Oncol. 2010 Mar;7(3):163-72
pubmed: 20101258
Surg Oncol. 2018 Dec;27(4):759-766
pubmed: 30449504
Health Place. 2019 Nov;60:102208
pubmed: 31627128
Surgery. 2020 Jul;168(1):106-112
pubmed: 32409168
JAMA. 2021 Sep 7;326(9):851-862
pubmed: 34547082
N Engl J Med. 2014 Sep 11;371(11):1039-49
pubmed: 25207767
Health Place. 2016 Nov;42:11-18
pubmed: 27614062
Rev Epidemiol Sante Publique. 2019 Feb;67 Suppl 1:S25-S32
pubmed: 30639053
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Eur J Surg Oncol. 2010 May;36(5):496-500
pubmed: 19748206
Br J Surg. 2016 Feb;103(3):267-75
pubmed: 26572509
Health Place. 2009 Dec;15(4):1100-7
pubmed: 19576837
Surgeon. 2010 Oct;8(5):239-46
pubmed: 20709279
PLoS One. 2018 Aug 16;13(8):e0202486
pubmed: 30114213
Ann Oncol. 2021 Apr;32(4):478-487
pubmed: 33626377
Ann Surg. 2016 Apr;263(4):664-72
pubmed: 26636243
J Gastrointest Surg. 2021 May;25(5):1261-1270
pubmed: 32378096